This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

Difference between revisions of "2016-10-19PC DrugAllergySubstance Call Minutes"

From HL7Wiki
Jump to navigation Jump to search
(Created page with " <!-- LOOK FOR THE APPROPRIATE SECTION ****** TO ENTER INFORMATION--> Back to Negation_Requirements ==Minutes Template== ===Meeting Information=== {|border="1" cellpadding...")
 
 
(6 intermediate revisions by the same user not shown)
Line 1: Line 1:
  
 
<!-- LOOK FOR THE APPROPRIATE SECTION ****** TO ENTER INFORMATION-->
 
<!-- LOOK FOR THE APPROPRIATE SECTION ****** TO ENTER INFORMATION-->
−
Back to [[Negation_Requirements]]
+
Back to [[Allergy_%26_Intolerance_Drug_Sub-project]]
 
==Minutes Template==
 
==Minutes Template==
 
===Meeting Information===
 
===Meeting Information===
Line 51: Line 51:
 
|-
 
|-
 
| y || Froukje Harkes-Idzinga
 
| y || Froukje Harkes-Idzinga
−
|colspan="2"|  
+
|colspan="2"| Nictiz
 
|-
 
|-
 
| y || Rob Hausam
 
| y || Rob Hausam
−
|colspan="2"|  
+
|colspan="2"| Hausam Consulting
 
|-
 
|-
 
| y || Serafina Versaggi
 
| y || Serafina Versaggi
−
|colspan="2"|  
+
|colspan="2"| Versaggi Consulting
 
|-
 
|-
 
| y || Joe Quinn
 
| y || Joe Quinn
−
|colspan="2"|  
+
|colspan="2"| Optum
 
|-
 
|-
 
|colspan="4" style="background:#f0f0f0;"|
 
|colspan="4" style="background:#f0f0f0;"|
Line 79: Line 79:
 
===Agenda===
 
===Agenda===
 
'''Agenda Topics''' <br/>
 
'''Agenda Topics''' <br/>
−
# review assessment content requirements
+
# confirm goals
−
## how many 'about' codes
+
# address open questions
−
## body site: coded, with modifier, and * (contiguous)
+
# identify gaps & tasks
−
## can we make 'related observation' more specific?
 
−
## composition: lab/exam then qual/quant, or vice versa? or compositional?
 
−
# review assertion content requirements
 
−
## course & mechanism are precoordinated in SCT
 
−
## drainage:
 
−
### confirm type list
 
−
### status: values?
 
−
### qualitative volume values?
 
−
## undermining & tunneling:
 
−
### properties, or new associated lesions? restrict their properties?
 
−
### normalize dimensional measurements to a single 'dimension/magnitude' property?
 
−
# concept alignment
 
−
## Is an assertion a finding?
 
−
## Is an evaluation an observable + a finding?
 
  
 
===Minutes===
 
===Minutes===
Line 110: Line 96:
  
 
'''Minutes/Conclusions Reached:'''<br/>
 
'''Minutes/Conclusions Reached:'''<br/>
−
* Jim had questions about the use of attribute bindings. Jay attempted to answer them, with the assistance of [[media:Candidate Approach for Semantic Binding.pptx | this]] slide.
+
* Netherlands working with ISO on drug safety db [https://www.knmp.nl/producten-en-diensten/gebruiksrecht-g-standaard/informatie-over-de-g-standaard/the-g-standaard-the-medicines-standard-in-healthcare here]
−
** Jim still has misgivings about using Situation, at least partly due to potential conflict between absence values & findings.
+
* Note: use case is patient safety, not adverse event reporting
−
* Jay to schedule offline  review of requirements with Susan due to scheduling conflicts
+
* Record what you know; so if Percocet is the trigger, record "acetaminophen and oxycodone." You can't choose one.
−
* We need to address code vs reference for devices, procedures, etc.
+
* Confirm: inactive ingredient reactions are very rare; our list will only include active ingredients
−
** For the finding, we are interested in the type (cuff, scale, thermometer, etc.), not the device itself.
+
* A clinician may record a specific product, but the substance is what goes in the allergy list
−
** But we might link to the device itself to support retrieval of the type
+
* Questions on site discussed. Most are TBD.
−
** Or we could assert that we don't care; if you link to support retrieval, go ahead and retrieve.
+
* How do we map?
−
*** If you need the device, record it under an actual procedure.
+
** Ask VA/DoD team to present
−
** If we decide we do need both, then are code & reference two distinct properties?
+
* What system?
−
* Consider 'link' for typed references.  
+
** SCT does not have MINs in substance hierarchy
−
** Claude: slicing is difficult
+
** Ask Larry to present IDMP
−
** Jay: define archetypes for Braden parts & panel; include parts in panel. Is that slicing, & is it difficult?
 
−
** tabled
 
−
* Precondition range is limited
 
−
** some required precondition values are findings, some qualifiers.
 
−
** request expansion of range to accommodate non-lab
 
−
** or just use related finding instead
 
−
** Jay to provide Vitals use case to Linda for consideration (review with Claude)
 
  
 
===Meeting Outcomes===
 
===Meeting Outcomes===
Line 143: Line 122:
  
 
| width="100%" align="left" style="background:#f0f0f0;"|'''Actions''' ''
 
| width="100%" align="left" style="background:#f0f0f0;"|'''Actions''' ''
 +
* Jay to invite contributors
  
−
* begin construction of test classes
 
  
 
|-
 
|-
Line 158: Line 137:
  
 
|width="100%" |'''Next Meeting/Preliminary Agenda Items'''<br/>
 
|width="100%" |'''Next Meeting/Preliminary Agenda Items'''<br/>
−
*Review test class progress & tooling
+
* get those who have mapped to describe process
 +
* become familiar with candidate systems
 
|}
 
|}
  
 
© 2012 Health Level Seven® International.  All rights reserved.
 
© 2012 Health Level Seven® International.  All rights reserved.

Latest revision as of 14:00, 19 October 2016

Back to Allergy_&_Intolerance_Drug_Sub-project

Minutes Template

Meeting Information

HL7 Negation Requirements Meeting Minutes

Location: Phone

Date: 2016-10-19
Time: 9:00-10:00 ET
Facilitator Jay Lyle Note taker(s) Jay Lyle
Attendee Name Affiliation


y Jay Lyle JP Systems / VA
y Froukje Harkes-Idzinga Nictiz
y Rob Hausam Hausam Consulting
y Serafina Versaggi Versaggi Consulting
y Joe Quinn Optum

Agenda

Agenda Topics

  1. confirm goals
  2. address open questions
  3. identify gaps & tasks

Minutes

Minutes/Conclusions Reached:

  • Netherlands working with ISO on drug safety db here
  • Note: use case is patient safety, not adverse event reporting
  • Record what you know; so if Percocet is the trigger, record "acetaminophen and oxycodone." You can't choose one.
  • Confirm: inactive ingredient reactions are very rare; our list will only include active ingredients
  • A clinician may record a specific product, but the substance is what goes in the allergy list
  • Questions on site discussed. Most are TBD.
  • How do we map?
    • Ask VA/DoD team to present
  • What system?
    • SCT does not have MINs in substance hierarchy
    • Ask Larry to present IDMP

Meeting Outcomes

Actions
  • Jay to invite contributors


Next Meeting/Preliminary Agenda Items
  • get those who have mapped to describe process
  • become familiar with candidate systems

© 2012 Health Level Seven® International. All rights reserved.

Retrieved from "https://wiki.hl7.org/w/index.php?title=2016-10-19PC_DrugAllergySubstance_Call_Minutes&oldid=127673"